Comparative proteomic analysis of cysteine oxidation in colorectal cancer patients

Molecules and Cells

Volumn 35, Issue 6, 2013, Pages 533-542

  Yang, Hee Young ^a   Chay, Kee Oh ^b   Kwon, Joseph ^c   Kwon, Sang Oh ^c   Park, Young Kyu ^d   Lee, Tae Hoon ^a  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

Colorectal cancer; Cysteine oxidation; Iodoacetamide; Protein network; Shotgun proteomics

Indexed keywords

A26C1A PROTEIN; ACTG1 PROTEIN; ACTG2 PROTEIN; ALPHA ACTININ 1; ALPHA ACTININ 3; ANKRD30B PROTEIN; ANXA2 PROTEIN; CLCA1 PROTEIN; COL6A1 PROTEIN; CYSTEINE; DGKZ PROTEIN; FKSG30 PROTEIN; HADHA PROTEIN; HSPA1A PROTEIN; HSPA1B PROTEIN; HSPA1L PROTEIN; HSPA6 PROTEIN; IGHA1 PROTEIN; IGHV4 31 PROTEIN; KRT10 PROTEIN; KRT18P33 PROTEIN; KRT4 PROTIEN; LMNA PROTEIN; MVP PROTEIN; MYH9 PROTEIN; PDIA3 PROTEIN; PDIA6 PROTEIN; PROTEOME; SLC25A5 PROTEIN; TPSAB1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CELL FUNCTION; CELL METABOLISM; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTEINE OXIDATION; FEMALE; HUMAN; HUMAN TISSUE; KOREA; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MIDDLE AGED; OXIDATION; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEOMICS; VERY ELDERLY;

EID: 84877587336     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-013-0058-1     Document Type: Article

References (62)

1. Abraham, A., Bencsath, F.A., Shartava, A., Kakhniashvili, D.G., and Goodman, S.R. (2002). Preparation of irreversibly sickled cell beta-actin from normal red blood cell beta-actin. Biochemistry 41, 292-296.
2. Acharya, A., Das, I., Chandhok, D., and Saha, T. (2010). Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid. Med. Cell Longev. 3, 23-34.
3. Adachi, M., Sakamoto, H., Kawamura, R., Wang, W., Imai, K., and Shinomura, Y. (2007). Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol. Histopathol. 22, 437-442.
4. Behrend, L., Henderson, G., and Zwacka, R.M. (2003). Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 31, 1441-1444.
5. Brennan, J.P., Wait, R., Begum, S., Bell, J.R., Dunn, M.J., and Eaton, P. (2004). Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J. Biol. Chem. 279, 41352-41360.
6. Bulaj, G., Kortemme, T., and Goldenberg, D.P. (1998). Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry 37, 8965-8972.
7. Burdon, R.H. (1995). Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18, 775-794.
8. Burdon, R.H., Gill, V., and Alliangana, D. (1996). Hydrogen peroxide in relation to proliferation and apoptosis in BHK-21 hamster fibroblasts. Free Radic. Res. 24, 81-93.
9. Chang, D.K., Goel, A., Ricciardiello, L., Lee, D.H., Chang, C.L., Carethers, J.M., and Boland, C.R. (2003). Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines. Cancer Lett. 195, 243-251.
10. Charles, R.L., Schroder, E., May, G., Free, P., Gaffney, P.R., Wait, R., Begum, S., Heads, R.J., and Eaton, P. (2007). Protein sulfe-nation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue. Mol. Cell. Proteomics 6, 1473-1484.
11. Chen, J.G., Yang, C.P., Cammer, M., and Horwitz, S.B. (2003). Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 63, 7891-7899.
12. Choi, H., Kim, S., Mukhopadhyay, P., Cho, S., Woo, J., Storz, G., and Ryu, S.E. (2001). Structural basis of the redox switch in the OxyR transcription factor. Cell 105, 103-113.
13. Choi, K.S., Park, S.Y., Baek, S.H., Dey-Rao, R., Park, Y.M., Zhang, H., Ip, C., Park, E.M., Kim, Y.H., and Park, J.H. (2006). Analysis of protein redox modification by hypoxia. Prep. Biochem. Biotechnol. 36, 65-79.
14. Coyle, J.T., and Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
15. Cumming, R.C., Andon, N.L., Haynes, P.A., Park, M., Fischer, W.H., and Schubert, D. (2004). Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem. 279, 21749-21758.
16. Dalle-Donne, I., Rossi, R., Milzani, A., Di Simplicio, P., and Colombo, R. (2001). The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic. Biol. Med. 31, 1624-1632.
17. Dionne, S., Levy, E., Levesque, D., and Seidman, E.G. (2010). PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis. Anticancer Res. 30, 157-166.
18. Domokos, M., Jakus, J., Szeker, K., Csizinszky, R., Csiko, G., Neo-grady, Z., Csordas, A., and Galfi, P. (2010). Butyrate-induced cell death and differentiation are associated with distinct patterns of ROS in HT29-derived human colon cancer cells. Dig. Dis. Sci. 55, 920-930.
19. Farah, M.E., Sirotkin, V., Haarer, B., Kakhniashvili, D., and Amberg, D.C. (2011). Diverse protective roles of the actin cytoskeleton during oxidative stress. Cytoskeleton (Hoboken) 68, 340-354.
20. Fedorova, M., Kuleva, N., and Hoffmann, R. (2010). Identification of cysteine, methionine and tryptophan residues of actin oxidized in vivo during oxidative stress. J. Proteome Res. 9, 1598-1609.
21. Finkel, T. (2003). Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254.
22. Fu, C., Wu, C., Liu, T., Ago, T., Zhai, P., Sadoshima, J., and Li, H. (2009). Elucidation of thioredoxin target protein networks in mouse. Mol. Cell Proteomics 8, 1674-1687.
23. Gao, J., Liu, X., and Rigas, B. (2005). Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc. Natl. Acad. Sci. USA 102, 17207-17212.
24. Gao, J., Kashfi, K., Liu, X., and Rigas, B. (2006). NO-donating aspirin induces phase II enzymes in vitro and in vivo. Carcinogenesis 27, 803-810.
25. 2-oxidized proteins. J. Proteomics 74, 2476-2486.
26. Giardina, C., Boulares, H., and Inan, M.S. (1999). NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochim. Biophys. Acta 1448, 425-438.
27. Grillo, C., D’Ambrosio, C., Consalvi, V., Chiaraluce, R., Scaloni, A., Maceroni, M., Eufemi, M., and Altieri, F. (2007). DNA-binding activity of the ERp57 C-terminal domain is related to a redox-dependent conformational change. J. Biol. Chem. 282, 10299-10310.
28. Janssen-Heininger, Y.M., Mossman, B.T., Heintz, N.H., Forman, H.J., Kalyanaraman, B., Finkel, T., Stamler, J.S., Rhee, S.G., and van der Vliet, A. (2008). Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 45, 1-17.
29. Kitz, K., Windischhofer, W., Leis, H.J., Huber, E., Kollroser, M., and Malle, E. (2011). 15-Deoxy-Delta12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species. Free Radic. Biol. Med. 50, 854-865.
30. Kozoni, V., Rosenberg, T., and Rigas, B. (2007). Development of novel agents based on nitric oxide for the control of colon cancer. Acta Pharmacol. Sin. 28, 1429-1433.
31. Landino, L.M., Hagedorn, T.D., Kim, S.B., and Hogan, K.M. (2011). Inhibition of tubulin polymerization by hypochlorous acid and chloramines. Free Radic. Biol. Med. 50, 1000-1008.
32. Lee, K.W., and Lee, H.J. (2006). Biphasic effects of dietary anti-oxidants on oxidative stress-mediated carcinogenesis. Mech. Ageing Dev. 127, 424-431.
33. Leonard, S.E., and Carroll, K.S. (2011). Chemical ‘omics’ approaches for understanding protein cysteine oxidation in biology. Curr. Opin. Chem. Biol. 15, 88-102.
34. Mastrocola, R., Reffo, P., Penna, F., Tomasinelli, C.E., Boccuzzi, G., Baccino, F.M., Aragno, M., and Costelli, P. (2008). Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress. Free Radic. Biol. Med. 44, 584-593.
35. Mates, J.M., and Sanchez-Jimenez, F.M. (2000). Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell Biol. 32, 157-170.
36. Matsubara, K., Komatsu, S., Oka, T., and Kato, N. (2003). Vitamin B6-mediated suppression of colon tumorigenesis, cell proliferation, and angiogenesis (review). J. Nutr. Biochem. 14, 246-250.
37. Milzani, A., Rossi, R., Di Simplicio, P., Giustarini, D., Colombo, R., and DalleDonne, I. (2000). The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci. 9, 1774-1782.
38. Miro, A.M., Sastre-Serra, J., Pons, D.G., Valle, A., Roca, P., and Oliver, J. (2011). 17beta-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio. J. Steroid Biochem. Mol. Biol. 123, 133-139.
39. Monaghan-Benson, E., and Burridge, K. (2009). The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J. Biol. Chem. 284, 25602-25611.
40. Nagahara, N., Matsumura, T., Okamoto, R., and Kajihara, Y. (2009). Protein cysteine modifications: (1) medical chemistry for proteomics. Curr. Med. Chem. 16, 4419-4444.
41. Olivieri, G., Novakovic, M., Savaskan, E., Meier, F., Baysang, G., Brockhaus, M., and Muller-Spahn, F. (2002). The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience 113, 849-855.
42. Pamplona, R., Dalfo, E., Ayala, V., Bellmunt, M.J., Prat, J., Ferrer, I., and Portero-Otin, M. (2005). Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J. Biol. Chem. 280, 21522-21530.
43. Parkin, D.M. (2006). The global health burden of infection-associa-ted cancers in the year 2002. Int. J. Cancer 118, 3030-3044.
44. Pelicano, H., Carney, D., and Huang, P. (2004). ROS stress in can- cer cells and therapeutic implications. Drug Resist. Updat. 7, 97-110.
45. Phalen, T.J., Weirather, K., Deming, P.B., Anathy, V., Howe, A.K., van der Vliet, A., Jonsson, T.J., Poole, L.B., and Heintz, N.H. (2006). Oxidation state governs structural transitions in peroxiredoxin II that correlate with cell cycle arrest and recovery. J. Cell Biol. 175, 779-789.
46. Poole, L.B., and Nelson, K.J. (2008). Discovering mechanisms of signaling-mediated cysteine oxidation. Curr. Opin. Chem. Biol. 12, 18-24.
47. Qin, G., Meng, X., Wang, Q., and Tian, S. (2009). Oxidative damage of mitochondrial proteins contributes to fruit senescen-ce: a redox proteomics analysis. J. Proteome Res. 8, 2449-2462.
48. Rigas, B. (2007). The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neopla-sia. Curr. Opin. Gastroenterol. 23, 55-59.
49. Roessner, A., Kuester, D., Malfertheiner, P., and Schneider-Stock, R. (2008). Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol. Res. Pract. 204, 511-524.
50. Saaf, A.M., Halbleib, J.M., Chen, X., Yuen, S.T., Leung, S.Y., Nelson, W.J., and Brown, P.O. (2007). Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol. Biol. Cell 18, 4245-4260.
51. Sampson, N., Koziel, R., Zenzmaier, C., Bubendorf, L., Plas, E., Jansen-Durr, P., and Berger, P. (2011). ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol. Endocrinol. 25, 503-515.
52. Stone, W.L., Krishnan, K., Campbell, S.E., Qui, M., Whaley, S.G., and Yang, H. (2004). Tocopherols and the treatment of colon cancer. Ann. N. Y. Acad. Sci. 1031, 223-233.
53. Sun, Y., and Rigas, B. (2008). The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 68, 8269-8277.
54. Veal, E.A., Day, A.M., and Morgan, B.A. (2007) Hydrogen peroxide sensing and signaling. Mol. Cell 26, 1-14.
55. Wang, X., Ling, S., Zhao, D., Sun, Q., Li, Q., Wu, F., Nie, J., Qu, L., Wang, B., Shen, X., et al. (2010). Redox regulation of actin by thioredoxin-1 is mediated by the interaction of the proteins via cysteine 62. Antioxid. Redox. Signal. 13, 565-573.
56. Weitz, J., Koch, M., Debus, J., Hohler, T., Galle, P.R., and Buchler, M.W. (2005). Colorectal cancer. Lancet 365, 153-165.
57. Werth, C., Stuhlmann, D., Cat, B., Steinbrenner, H., Alili, L., Sies, H., and Brenneisen, P. (2008). Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation. Carcinogenesis 29, 404-410.
58. Winterbourn, C.C., and Hampton, M.B. (2008). Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 45, 549-561.
59. Xu, D., Suenaga, N., Edelmann, M.J., Fridman, R., Muschel, R.J., and Kessler, B.M. (2008). Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol. Cell Proteomics 7, 2215-2228.
60. Yang, H.Y., Kwon, J., Park, H.R., Kwon, S.O., Park, Y.K., Kim, H.S., Chung, Y.J., Chang, Y.J., Choi, H.I., Chung, K.J., et al. (2012a). Comparative proteomic analysis for the insoluble fractions of colorectal cancer patients. J. Proteomics 75, 3639-3653.
61. Yang, H.Y., Kwon, J., Choi, H.I., Park, S.H., Yang, U., Park, H.R., Ren, L., Chung, K.J., Kim, Y.U., Park, B.J., et al. (2012b). In-depth analysis of cysteine oxidation by the RBC proteome: advantage of peroxiredoxin II knockout mice. Proteomics 12, 101-112.
62. Ziech, D., Franco, R., Pappa, A., and Panayiotidis, M.I. (2011). Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res. 711, 167-173.